:: Volume 21, Number 2 (3-2017) ::
IBJ 2017, 21(2): 120-125 Back to browse issues page
Association of ABCB1 (C3435T) and ABCC1 (G2012T) Polymorphisms with Clinical Response to Atorvastatin in Iranian Patients with Primary Hyperlipidemia
Niusha Behdad, Javad Kojuri, Negar Azarpira, Amir Masoomi, Soha Namazi
Abstract:  

Background:  Atorvastatin is prescribed for the primary and the secondary prevention of coronary artery diseases. A wide variation in inter-individual statin response suggests that genetic differences may contribute to this variation. This study investigated the association of ABCB1 (C3435T) and ABCC1 (G2012T) polymorphisms with clinical response to atorvastatin in Iranian primary hyperlipidemic patients. Methods: Individuals (n=179) with primary hypercholesterolemia were enrolled, and peripheral blood samples were collected. Genotyping of two polymorphisms were performed by amplification refractory mutation system PCR. Results: Following four weeks of treatment, a significant reduction of LDL-C was observed in variant groups (CT+TT) of ABCB1 (P=0.018) and wild-type group (GG) of ABCC1 genes (P=0.029). Logistic regression analysis revealed a significant difference between male and female responses to 10 mg/day atorvastatin (P=0.004, odds ratio=0.2, CI 95%=0.06-0.6). Conclusion: Our finding indicated that these polymorphisms may be attributed to LDL-C serum levels in the primary hypercholesterolemia patients receiving atorvastatin.

Keywords: Hypercholesterolemia, Statin, Gene polymorphisms
Full-Text [PDF 613 kb]      
Type of Study: Short Communication | Subject: Molecular Genetics & Genomics



DOI: 10.18869/acadpub.ibj.21.2.120
PMID: 27238935
PMCID: PMC5274711


XML     Print


Volume 21, Number 2 (3-2017) Back to browse issues page